Global PreScission Protease Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global PreScission Protease market size was valued at US$ 146 million in 2024 and is forecast to a readjusted size of USD 329 million by 2031 with a CAGR of 12.2% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
PreScission Protease is a fusion protein composed of human rhinovirus (HRV) type 14 3C protease and GST. The protease can specifically recognize the short peptide Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro at low temperature (4°C) and perform enzymatic cleavage between Gln and Gly amino acid residues. The recognition and cleavage of the substrate depends not only on the primary structure of the fusion protein but also on the secondary and tertiary structures of the fusion protein. It can specifically separate the GST tag of the fusion protein with enzyme substrate recognition peptide sequence expressed by vectors such as the pGEX-6P series.
PreScision protease is a new protein degradation technology developed and is an extension of the PROTAC (targeted protein degradation) technology platform. It activates the conditional protease system to achieve precise degradation of targeted proteins in specific tissues or cell environments. In recent years, with the development of precision medicine and protein degradation technology, PreScision protease is gradually becoming a hot spot in drug research and development, especially in the fields of anti-tumor and autoimmune diseases. In the future, its synergistic application with other protein degradation platforms (such as Molecular Glue, LYTAC, etc.) may further promote the diversity and target coverage of targeted drugs.
This report is a detailed and comprehensive analysis for global PreScission Protease market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global PreScission Protease market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global PreScission Protease market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global PreScission Protease market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global PreScission Protease market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PreScission Protease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PreScission Protease market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, TriAltus Bioscience, CYTOSKELETON, Genscript, Thermo Fisher Scientific, Nucleus Biotech, StemImmune, Beyotime, Yeasen, MedChemExpress, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
PreScission Protease market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity ≥ 95%
Purity < 95%
Market segment by Application
Medical Laboratories
University Laboratories
Others
Major players covered
Merck
TriAltus Bioscience
CYTOSKELETON
Genscript
Thermo Fisher Scientific
Nucleus Biotech
StemImmune
Beyotime
Yeasen
MedChemExpress
Aurora Biolabs
Novus Biologicals
SBS Genetech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PreScission Protease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PreScission Protease, with price, sales quantity, revenue, and global market share of PreScission Protease from 2020 to 2025.
Chapter 3, the PreScission Protease competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PreScission Protease breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and PreScission Protease market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PreScission Protease.
Chapter 14 and 15, to describe PreScission Protease sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
PreScission Protease is a fusion protein composed of human rhinovirus (HRV) type 14 3C protease and GST. The protease can specifically recognize the short peptide Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro at low temperature (4°C) and perform enzymatic cleavage between Gln and Gly amino acid residues. The recognition and cleavage of the substrate depends not only on the primary structure of the fusion protein but also on the secondary and tertiary structures of the fusion protein. It can specifically separate the GST tag of the fusion protein with enzyme substrate recognition peptide sequence expressed by vectors such as the pGEX-6P series.
PreScision protease is a new protein degradation technology developed and is an extension of the PROTAC (targeted protein degradation) technology platform. It activates the conditional protease system to achieve precise degradation of targeted proteins in specific tissues or cell environments. In recent years, with the development of precision medicine and protein degradation technology, PreScision protease is gradually becoming a hot spot in drug research and development, especially in the fields of anti-tumor and autoimmune diseases. In the future, its synergistic application with other protein degradation platforms (such as Molecular Glue, LYTAC, etc.) may further promote the diversity and target coverage of targeted drugs.
This report is a detailed and comprehensive analysis for global PreScission Protease market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global PreScission Protease market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global PreScission Protease market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global PreScission Protease market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global PreScission Protease market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PreScission Protease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PreScission Protease market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, TriAltus Bioscience, CYTOSKELETON, Genscript, Thermo Fisher Scientific, Nucleus Biotech, StemImmune, Beyotime, Yeasen, MedChemExpress, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
PreScission Protease market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity ≥ 95%
Purity < 95%
Market segment by Application
Medical Laboratories
University Laboratories
Others
Major players covered
Merck
TriAltus Bioscience
CYTOSKELETON
Genscript
Thermo Fisher Scientific
Nucleus Biotech
StemImmune
Beyotime
Yeasen
MedChemExpress
Aurora Biolabs
Novus Biologicals
SBS Genetech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PreScission Protease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PreScission Protease, with price, sales quantity, revenue, and global market share of PreScission Protease from 2020 to 2025.
Chapter 3, the PreScission Protease competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PreScission Protease breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and PreScission Protease market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PreScission Protease.
Chapter 14 and 15, to describe PreScission Protease sales channel, distributors, customers, research findings and conclusion.
Table of Contents
112 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: PreScission Protease by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
